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We show that Xenopus oocytes and embryos contain GATA-2, stored in nuclei as a non-chromatin-bound complex. Its
binding site speci®city is different from that of GATA-1, having a much higher af®nity for the motif with a core GATC
sequence. This binding site preference was markedly reduced by either release of the factor with deoxycholate or puri®cation
on a DNA af®nity column, suggesting a role for a cofactor(s). The identity of the maternal GATA factor was established
as GATA-2 in two ways: (1) binding to an oligonucleotide probe was abolished by inclusion of either of two GATA-2
monoclonal antibodies, and (2) a protein of correct molecular weight for GATA-2 was detected by immunoblotting with
a polyclonal antibody raised against a Xenopus GATA-2-speci®c peptide. Although predominantly complexed, some of the
oocyte GATA-2 is functional as a transcription factor because the transcriptional activity of the chicken bH-globin promoter
injected into oocytes was reduced by mutation of either of two GATA binding sites. This effect was more pronounced
when the stronger of the two sites was mutated. Butyrate treatment of oocytes stimulated cap-site initiation by up to 17-
fold with both normal promoter and GATA site mutant constructs, showing that the mechanism of butyrate stimulation
is not via GATA-2. The possible signi®cance of regulating the availability of maternal GATA-2 during early development
is discussed. q 1997 Academic Press
INTRODUCTION family members fall into two subgroups containing GATA-
1, -2, and -3 in one and GATA-4, -5, and -6 in the other.
These subgroups are de®ned by both sequence homologyThe GATA retinue of transcription factors consists of an
and expression patterns, with GATA-1, -2, and -3 predomi-enlarging family which share a high degree of homology in
nating in blood and ectodermal derivatives (Orkin, 1995),the amino acid sequence of the two zinc ®nger binding
and GATA-4, -5, and -6 predominating in heart and endoder-domains and a common consensus DNA binding sequence,
mal tissues (Simon, 1995; Jiang and Evans,1996). GATA-2A/TGATA(AG/GC) (Evans et al., 1988; Wall et al., 1988;
is found in endothelial cells, trophoblasts, and the nervousPerkins et al., 1989; Plumb et al., 1989). Initially, consider-
system, as well as in hematopoietic stem cells, mast cells,able attention was focused on GATA-1 (e.g., Perkins et al.,
and primitive erythroblasts. GATA-2-de®cient ES cells do1989; Martin and Orkin, 1990; Orkin, 1990) but subse-
not give rise to any cells of the hematopoietic lineage inquently the cloning of a further ®ve related proteins, termed
adult mouse chimeras (Tsai et al., 1994) thus showing thatGATA-2 to -6 was reported (Yamamoto et al., 1990; La-
GATA-2 plays a critical role in the maintenance and prolif-verriere et al., 1994; Jiang and Evans, 1996). The GATA
eration of hematopoietic stem cells. Hematopoietic devel-
opment has been investigated in a number of species, in-
cluding zebra®sh, Xenopus, chicken, and mouse (reviewed1,2 Present address: Imperial Cancer Research Fund, P.O. Box 123
in Zon, 1995; Leonard et al., 1993; Dzierzak and Medvinsky,Lincoln's Inn Fields, London WC2A 3PX, UK.
1995).3 To whom correspondence should be addressed. Fax: 0171-497-
9078. Reports thus far on GATA-2 expression during Xenopus
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embryogenesis have concentrated exclusively on mRNA de- tube at 800g for 5 min at 47C, washed in 1 ml of LS buffer,
recentrifuged, and resuspended in 3 vol of LS buffer con-tection (Zon et al., 1991; Walmsley et al., 1994; Kelley et
al., 1994). These studies have indicated that GATA-2 is taining, in addition to the above inhibitors, 0.05% (v/v) Tri-
ton X-100. The cells were left on ice for 15 min with occa-present in the embryo as a maternal mRNA. The zygotic
commencement of GATA-2 transcription can be detected sional inversion. The nuclei were pelleted by centrifugation
at 3000g, 5 min, 47C, and were resuspended in 3 vol of LSduring gastrulation by in situ hybridization. Initially this is
throughout the ventral and lateral regions, predominantly buffer. One-tenth volume of 4 M NaCl was then slowly
added while stirring with the pipet tip. The nuclei were leftwithin the nonneural ectoderm, re¯ecting negative control
by dorsalizing factors (Walmsley et al., 1994). Subsequently, on ice for 20 min with occasional inversion. The chromatin
was pelleted by centrifugation for 20 min at 15,000g, 47C.strong expression is seen in the presumptive blood islands
of the tailbud embryo, as would be expected given the The supernatant was made up to 20% glycerol (w/v) and
stored in aliquots at 0707C after snap freezing.known role of this factor in hematopoeisis (Walmsley et al.,
1994). Puri®cation of oocyte extracts by DNA af®nity chroma-
tography. Oocyte GATA factor was puri®ed on an aG2To extend our understanding of the role of GATA factors
during Xenopus development, we describe experiments di- af®nity column as described (Nicolas and Goodwin, 1993)
with the following modi®cations: GV extract (30 GV/50rected at determining whether any maternal GATA factors
could be detected at the protein level in oocytes and em- ml) was diluted into 1ml of NS100 buffer, containing 5 mg
poly(dI:dC)(dI:dC). The extract was left on ice for 30 minbryos prior to the commencement of zygotic transcription,
that is prior to the mid-blastula transition (MBT) (Nieuw- and centrifuged at 15,000g, 10 min at 47C. The supernatant
was passed twice down a 0.4-ml aG2 af®nity column. Thekoop and Faber,1967). We observe a single, functionally ac-
tive GATA binding activity in oocytes which we show is column was then washed with 51 0.5 ml fractions of NS100
buffer. The bound fraction was eluted with 4 1 0.5 ml ali-GATA-2 by the use of GATA-2 antibodies. This factor is
located in the nucleus as part of a non-chromatin-bound quots of NS400 buffer.
Electrophoretic mobility shift assay. The method usedcomplex from which it can be released by treatment with
sodium deoxycholate (DOC). The complex survives for the assay of DNA binding proteins in extract prepara-
tions was as previously described (Perkins et al., 1989). Thethroughout early development, thereby contributing to the
regulation of the activity of this transcription factor. double-stranded oligonucleotides used as probes were the
aG2 GATA-1 binding oligonucleotide and mutants aG8-10
(Plumb et al., 1989), and the GATC oligonucleotide charac-
terized as having high GATA-2, GATA-3 and low GATA-MATERIALS AND METHODS
1 binding activity (Ko and Engel, 1993).
Preparation of extract from oocyte nuclei (germinal vesi-
GATCCGGGCAACTGATAAGGATTCCCA aG2
cles). Manually isolated stage VI (Dumont, 1972) oocyte GVs
GATCCGGGCAACTGACAAGGATTCCCA aG8
(generally about 80) were collected in 1 ml/GV of LS buffer
GATCCGGGCAACTGATATAGATTCCCA aG9
composed of 20 mM Hepes, pH 7.9, 2 mM MgCl2, 0.5 mM GATCCGGGCAACTGATACAGATTCCCA aG10
phenylmethylsulfonyl ¯uoride (PMSF), 0.5 mM benzamidine,
GATCCGAAGGAAAGATAGCAAATTTTA bHB
1 mg/ml pepstatin, 1 mg/ml leupeptin, 1 mg/ml aprotinin, 5 mg/
GGATAAAGATCTTAACTTGTTC GATC
ml bestatin, 1 mM b-glycerophosphate, and 2 mM levamisole.
Glycerol (20%, w/v) was added and aliquots of the extract The mutated bases in aG8, aG9, and aG10 are shown in
bold type. Poly(dI:dC)±poly(dI:dC) heteropolymer was usedwere snap-frozen and stored at 0707C.
Preparation of Xenopus embyro total protein extracts. as the nonspeci®c competitor in all experiments, at a con-
centration of 2.5 mg/ml for af®nity-puri®ed GATA, 25 mg/Embyros (generally about 20) were homogenized in 1 ml/
embyro of LS buffer in a siliconized 1 ml homogenizer and ml for GV extract and 50 mg/ml for all erythroid cell ex-
tracts.the homogenate was gently shaken with an equal volume
of freon (1,1,2-trichlorotri¯uoroethane) to remove yolk pro- Oocyte library screening. A Xenopus oocyte cDNA li-
brary (Rebagliati et al., 1985) was screened by plating ontoteins (Wyllie et al., 1978). The extract was centrifuged at
6000g, 47C, 10 min; the aqueous phase was gently removed, 24 1 144-mm diameter plates with LE392 bacteria at a den-
sity of 5 1 104 plaque-forming units per plate. Duplicateglycerol was added as for oocyte extract, and aliquots were
snap frozen at 0707C. ®lters were taken from each plate and hybridised in 61 SSC
for 16 hr at 607C with a 350-bp 32P-labeled fragment of thePreparation of nuclear extract from chicken embyro,
Xenopus adult, and tadpole red blood cells. Blood was Xenopus GATA-1 clone spanning the zinc ®nger region
(Zon et al., 1991). The ®lters were then washed in 21 SSCdiluted into cold PBS containing 5 mM EDTA, 2 mM leva-
misole, 1 mM b-glycerophosphate, 0.5 mM PMSF, and 0.5 at 657C and exposed for autoradiography. Twenty-one dupli-
cated positive plaques were picked and replated at 103 PFUmM benzamidine. The cells were pelleted by centrifugation
at 800g for 5 min at 47C and washed by resuspension and per plate on 144-mm-diameter plates. Duplicated ®lters
were then taken and hybridized at 607C in 61 SSC with arecentrifugation in 40 ml of PBS. The pelleted cells were
resuspended in 1 ml of PBS and centrifuged in an Eppendorf 600-bp 32P-labeled fragment of the Xenopus GATA-2 cDNA
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clone (Walmsley et al., 1994), 3* to the zinc ®nger region. binding sites, respectively (see Fig.7) were constructed from
this clone. pbH-98Eco was digested with SpeI and HindIIIThe ®lters were washed for 30 min in consecutively, 21
SSC, 11 SSC, 0.51 SSC, and 0.11 SSC at 657C before autora- (a polylinker site) and the fragment with either the X box
or C box mutation synthesized from complementary stranddiographic exposure.
Polyclonal antibodies. The sequences of the peptides oligonucleotides were each ligated into the construct. The
sequence alteration, converting both regions to BamHI rec-used to raise the polyclonal antibodies are listed:
ognition sites, is at the X box site GGATCC and at the C
C61 SPVFQVYPLL..NSMEGIP(C)
box site is GATCCTGA.
SPVFQTFPLHWPETSAGIPSXenopus GATA-1A,1B sequence
Microinjection of oocytes. The microinjection tech-
C13 ME(P)(V)ALGGC /MEF(V)ALGG(C)
nique and incubation of the injected stage VI oocytes (Du-
GATA2D (C)KTALSAAHHHNPWTVS
mont, 1972) (usually 20 to 30 oocytes per injected construct)
was as previously described (Proudfoot et al., 1984) exceptThese antibodies were raised as described previously (Nico-
las et al., 1991). A mixture of the peptides shown was used that injected oocytes were cultured for 24 hr before RNA
extraction. RNA extraction of the pooled oocytes was asto raise the antibody C13. P and V are not present in the
chicken GATA-1 sequence. The C- or N-terminal cysteine described (Partington et al., 1984) except that the organic
phase was not reextracted.residues were added for linking to the column.
Western blotting. Samples were electrophoresed in an S1 mapping. The amount of extracted total oocyte RNA
was determined for each assay and equal quantities of RNA11% SDS±polyacrylamide gel and transferred to Immobilon
P membrane (Millipore) using a wet blotter with 10 mM were used for assay by 5* end S1 nuclease mapping. bH-globin
gene transcripts were mapped using a single-strand 601-baseCaps buffer, pH 10, 10% (v/v) methanol. For detecting the
GATA-2 protein, the blot was blocked for nonspeci®c pro- 32P 5*-endlabeled probe prepared from a PvuII fragment of
the bH gene spanning nucleotides 666 to 65 and strand sepa-tein binding by incubation for 1 hr in PBS containing 0.1%
(w/v) Tween 20 and 1% (w/v) fat-free milk powder. The blot rated as described previously (Proudfoot et al., 1984; see Fig.
7). The probe DNA was annealed to each RNA sample atwas then washed three times in PBS±Tween for 5 min per
wash and incubated for 2 hr with the polyclonal GATA-2 687C for 16 hr in 10 ml of buffer (0.6 M NaCl, 20 mM Tris±
HCl, pH 7.5, 1 mM EDTA, 0.1% (w/v) SDS). Each assay wasantibody (dilution 1:300) which had been chromatographi-
cally puri®ed by passage over the cognate peptide column. diluted into 100 ml of ice-cold S1 buffer (0.25 M NaCl, 0.03
M Na acetate, pH 4.6, 1 mM ZnSO4, 20 mg/ml sonicatedThe peptide was linked to 3 M Emphaze Biosupport medium
AB1 (Pierce) and puri®cation of the antibody was as recom- salmon sperm DNA) and S1 (Pharmacia) 15±36 units/assay
was added to each assay. Digestion was for 40 min at 377C.mended by the manufacturers. The secondary antibody
(anti-rabbit Ig diluted 1:2000 Amersham) was incubated The reaction products were then precipitated by the addition
of 350 ml of ethanol, together with 12 mg of yeast tRNA, 10with the blots for 1 hr and the ®nal washing was as pre-
viously described, except for a fourth wash in 50 mM Tris± ml of 100 mM EDTA, and 14 ml of 2 M sodium acetate. The
precipitates were then redissolved in 90% formamide, 5 mMHCl, pH 7.5, and 100 mM NaCl. The blot was then devel-
oped with ECL reagent (Amersham). EDTA, heated to 907C and fractionated by electrophoresis
on denaturing 7 M urea, 6% polyacrylamide gels. Each analy-Construction of bH gene plasmids. The bH globin gene
fragment was excised from the genomic clone pCBG11 (Vil- sis was repeated at least three times.
Densitometry. Autoradiographs were scanned using ei-leponteau et al., 1982) by digestion with BamHI which cuts
on either side of the gene. The isolated bH fragment was ther a Joyce Loebl Chromoscan 3 densitometer or a BioRad
phosphoimager.ligated into BamHI-restricted pUC9 to give pbH-123Bam.
To prepare pbH-2.3Bam the clone was restricted with SpeI
and BamHI and the gene fragment was isolated. This frag-
ment was ligated together with 2.3 kb of 5*-¯anking se- RESULTS
quences of the bH-globin gene (produced by restricting
pb2EH325 (Plumb et al., 1986) with HindIII and SpeI) into Xenopus Oocytes Contain a Single GATA Binding
HindIII- and BamHI-digested pUC9. Derivatives of the Activity with DNA Sequence Preferences Distinct
clones pbH-123Bam and pbH-2.3Bam with truncated 3* from GATA-1
ends (pbH-123Eco, pbH-2.3Eco) were produced by re-
stricting each clone with EcoRI and religating. This removes To determine if the protein for any GATA family member
is present in oocytes, extract prepared from manually isolated600 bp downstream of the polyadenylation signal.
To construct bH clone pbH-98Eco a clone of the 5* 600- oocyte germinal vesicles (GVs) was fractionated on a GATA
factor-binding DNA af®nity column to avoid the potential forbp PvuII fragment (see Fig.7) was digested with PstI and SpeI
and the 66-bp fragment was isolated on a 5% polyacryl- nonspeci®c binding to the probe by the extractable nonchro-
matin bound pool of histones (Dilworth et al., 1987) or storedamide gel. This fragment was ligated into PstI and EcoRI cut
pUC9 together with the SpeI±EcoRI fragment from pbH- transcription factors (Wolffe, 1991). Aliquots of the bound frac-
tions were assayed for binding activity to a canonical GATA123Bam. The derivatives of this clone pbH-98XEco and
pbH-98CEco with mutations in the X and C box protein binding site (aG2) probe and a single binding activity was
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FIG. 1. EMSA showing the competition characteristics of speci®c and nonspeci®c oligonucleotides to binding of the Xenopus RBC
extract GATA-1, to binding by the af®nity column puri®ed oocyte GATA, with 32P aG2 as probe (20 fmol/assay). (A) Oocyte DNA af®nity
column puri®ed GATA. (B) Adult Xenopus RBC extract. Unlabeled competitor oligonucleotides (1 pmol/lane) or HaeIII-digested fX174
(10 ng/lane) was added where indicated. XboxM and CboxM oligonucleotides were added at the femtomole per assay concentrations
indicated.
detected (Fig. 1A, lane 1) which is completely competed by bind to the sequence with a GATC core with much higher
both self (lane 2) and the GATA binding site B from the pro- af®nity than GATA-1 (Ko and Engel, 1993). To further char-
moter of the chicken bH gene (lane 6) (Plumb et al., 1986). acterize the oocyte GATA factor, EMSA was carried out us-
No competition was observed with either an oligonucleotide ing the GATC oligonucleotide as a probe. The fractions from
speci®c for nuclear factor one (NF1) binding or fX174 phage the aG2 column (Fig. 2, lanes 1±4) clearly bind to GATC
DNA (lanes 7 and 8). A comparison was also made of the (Fig. 2, lanes 5, 8, 11, and 14). Furthermore, fractions 2 and
binding characteristics of oocyte GATA with the erythrocyte 3 are the peak fractions using both probes. We therefore con-
GATA-1 factor by competition with mutants of theaG2 oligo- clude that there is one GATA binding activity in the oocyte
nucleotide aG8, aG9, and aG10 (see Materials and Methods) and that it binds to the GATC probe as well as aG2.
(Figs. 1A and 1B, lanes 3±5). aG8 was able to compete for
binding of the oocyte GATA factor but had less effect on
erythrocyte GATA-1 binding, a ®nding which is in agreement
with the original observation that mouse GATA-1 binding
was unaffected by competition with this oligonucleotide
(Plumb et al., 1989). Similarly aG9 and aG10 show strong
competition in respect to the oocyte GATA factor binding but
less competition for the erythrocyte GATA-1. We therefore
conclude that only one GATA binding activity is detected in
oocytes with the aG2 probe and that this protein has DNA
sequence binding preferences distinct from those of GATA-1.
In agreement with this conclusion, the oocyte GATA factor
was found not to supershift with GATA-1-speci®c antibodies
which supershift the Xenopus erythrocyte GATA-1 (data not
shown). The presence of the oocyte GATA factor in GV ex-
tracts demonstrates that it is located in the nucleus, and its
absence from extracts prepared from enucleated oocytes
shows that this represents all of the GATA binding activity
(data not shown). However, although it is in the GV, the ma-
ternal GATA factor is predominantly not chromatin-bound
because low- and high-salt extractions yield identical amounts
of the factor (data not shown).
FIG. 2. EMSA showing that oocyte GATA puri®ed on an aG2Maternal GATA Factor Is complexed in Oocytes
DNA af®nity column also binds to the GATC probe. Lanes 1, 5,and throughout Early Development In¯uencing the 6, and 7 contain column-bound fraction 1; lanes 2, 8, 9, and 10
Binding Speci®city contain fraction 2; lanes 3, 11, 12, and 13 contain fraction 3; lanes
Binding site preferences distinct from GATA-1 have been 4, 14, 15, and 16 contain fraction 4. Unlabeled competitor oligonu-
cleotides (1 pmol/assay) were added as indicated.reported for GATA-2 and -3. In particular, GATA-2 and -3
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(compare lanes 1 with 4 and 7 with 10). Thus, the majority
of the oocyte GATA factor is in a form that binds to neither
oligonucleotide. The release for DNA binding by DOC
treatment suggests that association with cofactors is again
responsible. Thus, in addition to regulating the choice be-
tween GATA and GATC, cofactor association appears to
modify the binding site preferences of the oocyte GATA
factor to the point where neither GATA nor GATC are
recognized.
In order to determine when during development the ma-
ternal GATA factor is released from its complex, we ex-
tended the analysis to embyro extracts (Fig. 4). Using the
GATC oligonucleotide as a probe it can be seen that pre-
treatment with DOC of whole cell extracts prepared from
Xenopus embryos at stages 6 (prior to MBT) and 17 (post-
MBT) of development also showed a comparable increase
in the level of self-competed binding activity, with similar
mobility to that seen in oocytes (cf. lanes 1±3 to lanes 4±
9). To establish that this effect of DOC on GATA factor
binding is not a general phenomenon, its effect on chicken
FIG. 3. EMSA showing a comparison of oocyte GATA factor bind- embryo red blood cell GATA-2 factor binding was investi-
ing to the aG2 and the GATC probes and factor release after DOC gated. No enhancement was seen in the level of GATA-2
treatment of extract. An equal volume of 1% DOC was added to binding when this extract was treated with DOC (cf. lanes
aliquots of extract, and left on ice for 30 min prior to dilution with 10 and 11). Extracts were also prepared from embryos at
binding buffer and labeled probe. Unlabeled competitor oligonucle-
otides (1 pmol/assay) where added where indicated. 32P-labeled aG2
and GATC-labeled probes (20 fmol/assay) were used as indicated.
In Fig. 2, the af®nity of the oocyte factor for GATC is
slightly greater than for aG2 (compare signal intensities in
lanes 1 and 5, 2 and 8, 3 and 11, 4 and 14, respectively).
However, in the crude extract prior to af®nity puri®cation,
this difference is greater (Fig. 3, compare lanes 1 and 7), with
signi®cantly more binding activity being detected with the
GATC probe (lane 7) than with aG2 (lane 1). When the
signals were quantitated, we found that the preference for
GATC was 5-fold in the crude extract and reduced to 1.4-
fold by puri®cation on the DNA af®nity column.
The loss of speci®city by passage down the DNA af®nity
column may re¯ect the loss of cofactors, especially since
the running buffer contains detergent (see Materials and
Methods). To test this idea, crude extract was treated with
deoxycholate (DOC), prior to analysis by EMSA (Fig. 3), a
technique ®rst used to demonstrate that the transcription
factor NFkB could be released from a cytoplasmic complex
(Baeuerle and Baltimore, 1988). The preference for the
GATC probe over the aG2 probe (lane 7 compared to lane
1) was reduced when the extract was treated with DOC
(compare lane 10 with lane 4). Quantitation of these signals
shows that the sequence distinction of crude oocyte extract
is reduced from ®ve- to twofold by treatment with DOC, in
FIG. 4. EMSA showing that treatment of Xenopus embyro ex-
a similar manner to af®nity chromatography. We therefore tracts with DOC releases GATA factor to give increased binding
conclude that the maternal GATA factor is associated with to oligonucleotide probe. DOC treatment as for Fig.3. Unlabeled
cofactors which modify its sequence preference. competitor oligonucleotide GATC (1 pmol/assay) was added to the
In Fig. 3, the binding to both aG2 and GATC was in- lanes indicated. The 32P-labeled probe used was GATC (20 fmol/
assay).creased sevenfold by treatment of the extract with DOC
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FIG. 5. EMSA demonstrating that GATA-2 monoclonal antibodies recognize the oocyte GATA factor. Chicken RBC, Xenopus adult
RBC, Xenopus tadpole RBC and oocyte extracts are in lanes as shown. Monoclonal GATA-2 antibody 27 is present in lanes 2, 7, 10, and
13. Monoclonal GATA-2 antibody 96 is present in lanes 3, 8, 11, and 14. Lane 4: polyclonal chick GATA-1 antibody C13. Lane 6: polyclonal
Xenopus GATA-1 antibody C61. Probes used were either 32P-labeled aG2 or GATC as indicated.
several other stages of development post-MBT and analyzed with a probe from the zinc ®nger region of Xenopus GATA-
1. This was performed at a stringency known to permitby EMSA and no change in the level of complexed or un-
complexed GATA protein up to stage 31 of development cross-hybridization with other family members. We de-
tected 21 positive clones all of which rescreened positivewas observed (data not shown).
In conclusion we have shown by two separate experimen- using a GATA-2-speci®c probe. Thus from this approach
the predominant family member for which maternal RNAtal approaches, namely af®nity chromatography puri®ca-
tion and DOC treatment of extract, that the binding speci- has been detected is GATA-2.
®city of the maternal GATA factor can be altered, most
likely by disruption of cofactor associations. Binding to both
The Identity of the Oocyte Binding Activity IsGATA and GATC is substantially increased but the en-
Established to Be GATA-2 by Monoclonalhanced af®nity for GATC in comparison to GATA seen
Antibodieswith the untreated extract is considerably reduced. Associa-
tion with cofactors continues throughout early develop- We determined whether GATA-2 monoclonals 27 and 96,
which recognize chicken, mouse, and human GATA-2 spe-ment, likely exerting signi®cant in¯uence over GATA fac-
tor activity. cies (27, Z. Yang and J. D. Engel, unpublished results; 96,
Santa Cruz Biotechnology Inc.) would also recognize and
hence affect the binding of the oocyte GATA factor (Fig. 5).
cDNA Library Screening Detects GATA-2 RNA to Binding to the GATC probe was greatly reduced when chick
Be the Predominant GATA RNA Species embryo RBC extract was preincubated with either of the
in Oocytes monoclonals prior to EMSA (compare lane 1 to lanes 2 and
3), whereas binding was unaffected when the anti-chickenBoth GATA-2 amd GATA-5 coding RNAs have been de-
tected in Xenopus oocytes and pre-MBT eggs (Zon et al., GATA-1 polyclonal antibody (C13, Nicolas et al., 1991) was
included (lane 4). Monoclonal antibody 27 did not signi®-1991; Walmsley et al., 1994; Jiang and Evans, 1996). Thus
far neither GATA-1, GATA-3, GATA-4, nor GATA-6 RNA cantly affect the binding of Xenopus GATA-1 to the aG2
probe (compare lane 5 to lane 7) and antibody 96 onlyhave been detected, even by PCR (Zon et al., 1991; Jiang
and Evans, 1996). To determine which of the two detected slightly reduced binding (compare lane 5 to lane 8), thus
con®rming the preference of these antibodies for GATA-2.GATA RNA species is the more abundant, we screened
more than a million clones from an oocyte cDNA library Inclusion of the anti-Xenopus GATA-1 polyclonal antibody
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(56 kDa) than the 54-kDa Xenopus protein. This result is
in agreement with Yamamoto et al. (1990) who reported an
identical size for chicken GATA-2 synthesized in pro-
grammed reticulocyte lysate. Wheat germ extract was pro-
grammed with in vitro synthesized Xenopus GATA-2
mRNA and an autoradiograph of the in vitro 35S-labeled
synthesized protein (lane 5) shows a band of similar molecu-
lar weight to the antibody-detected GV GATA and one of
lower molecular weight (band B) which probably represents
incomplete translation of the RNA. Comparison of the
GATA-2 antibody binding to programmed (lane 7) and un-
programmed (lane 6) extract shows that the former contains
two extra bands, both identical to the labeled in vitro syn-
thesized GATA-2. The high background of antibody binding
with wheat germ extract is most probably attributable to
the high protein content of this extract (30 mg/ml). No bind-
ing by the secondary antibody was observed to either GV
or chicken RBC extract when this was used alone (dataFIG. 6. Immunoblot showing that GATA-2 can be detected in
not shown). Immunoblotting with another Xenopus anti-GV and chicken embyro RBC extract using puri®ed GATA2D, a
peptide GATA-2 antibody of different speci®city also de-polyclonal GATA-2 anti-peptide antibody. Lanes 1 to 3 contain 2,
tected a protein in oocytes and pre-MBT embyros with the1, 0.5 equivalents of GV extract, respectively. Lane 4: 30 mg chicken
same molecular weight (data not shown), further con®rm-embyro RBC extact. Lane 5: autioradiograph of 35S Xenopus GATA-
2 synthesized in wheat germ extact. Lane 6: unprogrammed; lane ing that GATA-2 is a maternal transcription factor.
7: programmed wheat germ extract. The blot was exposed to the
GATA-2 antibody and detected by ECL reagent as described under
A Proportion of Oocyte GATA-2 IsMaterials and Methods. An arrow shows the position of GATA-2.
Transcriptionally FunctionalBands A and B are discussed in the text.
To test whether any of the oocyte GATA-2 is available
to act as a functional transcription factor, oocytes were mi-
croinjected with deletion mutants of the chicken bH-globin
(C61) resulted in a supershift (lane 6). Preincubation of af- gene. This gene was chosen because we had shown that the
®nity-puri®ed oocyte GATA protein with either mono- GATA binding site B of the bH gene can compete with the
clonal prior to EMSA resulted in complete inhibition of GATC oligonucleotide for oocyte GATA-2 binding (Fig. 1A,
binding (compare lane 12 to lanes 13 and 14), and similarly lane 6) and furthermore we have also shown that GATA-2
binding of the GATA factor detected in Xenopus tadpole from erythroid cells can bind to this site (data not shown).
red blood cell extract using the GATC probe was also greatly The promoter of the chicken bH-globin gene and the posi-
reduced by inclusion of the monoclonal antibodies (com- tions of some of the known binding sites for avian transcrip-
pare lane 9 to lanes 10 and 11). We conclude that the DNA tion factors present in erythroid cells are shown (Fig. 7).
binding activities of the GATA factors in oocytes and tad- One of these is GATA-1 which has been shown to have
pole red blood cells, unlike those of the GATA-1 in adult red four binding sites within the promoter region (Perkins et
blood cells, are inhibited by monoclonal antibodies against al., 1989), two of which (C and X) are in the sequence in
GATA-2. Fig. 7 and the other two, including site B, are upstream of
the Pst site. Three other proteins present in avian erythroid
cells have been detected binding within this promoter inThe Oocyte GATA Factor Is Con®rmed to Be
vitro, a CCAAT-box factor (Perkins et al., 1989), nuclearGATA-2 by Immunoblotting
factor-1 (NF1, Rupp et al., 1988) and an Sp1-like protein
(unpublished data). To assay for transcription, the 5* endsCon®rmation of the presence of GATA-2 in oocyte GV
was obtained by immunoblotting with an antibody of the bH-globin gene transcripts synthesized in injected
oocytes were mapped using S1 nuclease. When clone pbH-(GATA2D, see Materials and Methods) raised against a pep-
tide (amino acids 102±117) unique to Xenopus GATA-2 2.3BamEco (see Fig. 7), which has about 2.3 kb of 5* ¯anking
DNA and 0.6 kb of 3* ¯anking DNA, was injected into(Fig. 6). Lanes 1 to 3 show that GV extract contains a major
band (arrowed) of about 54 kDa which is consistent with the oocytes the major transcriptional initiation site was identi-
cal to that of mRNA transcribed in 14-day chick embryopredicted amino acid sequence of Xenopus GATA-2 (Zon et
al., 1991), and an additional higher molecular weight band red blood cells (Fig. 8, compare lanes 1 and 9). However,
signi®cant transcription was also observed initiating about(band A) of 64 kDa which may result from a modi®cation
of GATA-2 in oocytes. Chicken embryo red blood cell ex- 3±5 bp upstream of the normal cap site. Furthermore, low
levels of nonspeci®c transcription were detected further up-tract (lane 4) also shows a major band which is slightly larger
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et al., 1986). Two mutant constructs of the -98 clone were
synthesized. The strong GATA-1 binding site C was mu-
tated to give clone pbH-98CEco, and the weak GATA bind-
ing site X was mutated to give clone pbH-98XEco; hence,
FIG. 7. Partial sequence and restriction enzyme map of the 5*
¯anking region of the chicken bH-globin gene. The position of the
cap site of transcription is marked by a right-angled arrow. The
known chicken RBC factor binding sites are shown (Perkins et al.,
1989).
stream of the cap site in the 5*-¯anking region of the gene.
Transcription of the bH-globin gene constructs truncated at
the 5* BamHI and PstI sites (pbH-123Bam and pbH-98Eco,
Fig. 7) was also initiated at the authentic cap site but sig-
ni®cantly greater amounts of initiation were evident in the
5*-¯anking regions of the gene, some of which were initi-
ated over the TATA box (T) region (Fig. 8, lanes 5 and 7).
There were also major signals at the mismatch points (M)
between the probe and each truncated clone which repre-
sent all the transcripts initiated in the plasmid vector. No
effect on the level of transcripts was observed whether the
clone terminated at the 3* EcoRI site or 600 bp further 3*
at the BamHI site (Plumb et al., 1986, Fig. 8, compare lanes
1 and 3). In order to enhance the cap site signal, injected
oocytes were treated with butyrate, which has been shown
FIG. 8. Analysis by 5* end S1 mapping of the transcripts produced
previously to elevate the levels of transcription from the from bH-gene constructs injected into oocytes, incubated with and
human g-globin gene cap site (Partington et al., 1984). All without 30 mM butyrate after injection. Injected oocytes were incu-
bH clones tested showed enhancement of cap site transcrip- bated for 24 hr before extraction of RNA. 10 ng of each bH-gene
tion (Fig. 8, lanes 2, 4, 6, and 8) in the range 6- to 17-fold construct was injected per oocyte. 30 mg of total oocyte RNA was
used for each S1 assay, and the S1 probe used was the single-in eight experiments. Furthermore, nonspeci®c initiation
stranded antisense strand from the PvuII fragment (see Fig. 8). Laneswas not stimulated by butyrate to the same extent as the
1, 3, 5, and 7 show injection of bH-gene constructs into oocytescorrect cap site initiation.
incubated without butyrate and lanes 2, 4, 6, and 8 show assays ofThe ®nding that transcripts were initiated at the in vivo
butyrate-treated injected oocytes. Lanes 1 and 2, injection of pbH-cap site with the injected clone pbH-98Eco (Fig. 8, lanes 7
2.3Bam. Lanes 3 and 4, pbH-2.3Eco. Lanes 5 and 6, pbH-123Bam.and 8) showed that factor binding sites upstream of -98,
Lanes 7 and 8, pbH-98Eco. Lane 9, 2.4 mg of total 14-day chick
including GATA binding site B, were not required to obtain embryo red blood cell RNA. Lane M denotes HaeIII-digested fX174
correct cap site transcription in oocytes. Consequently, we DNA marker. On the left of the ®gure is denoted from top to
focused on the role of the two previously characterized bottom: P, full-length probe; M, probe and transcript mismatch
GATA-1 binding sites contained within the -98 region: the bands; T, TATA box site; Cap, authentic cap-site transcripts. Unin-
jected oocyte RNA showed no hybridization to probe (not shown).strong GATA binding site C and the weaker site X (Plumb
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box region (bands T). The reason for this is not known.
The shorter ``M'' bands correspond to cleavage by the S1
nuclease at the Cbox or Xbox mutations and re¯ect initia-
tion within the plasmid sequence. From these results it is
evident that the GATA sites contribute to the ef®ciency of
cap site initiation, suggesting that some of the oocyte
GATA-2 is available to act as a functional transcription
factor.
We used EMSA to check that the oocyte GATA-2 can
bind to sites C and X which were originally characterized
as GATA-1 binding sites. Oocyte GATA-2 binding to the
aG2 probe was competed over a range by oligonucleotides
spanning both sites and containing mutations in either the
C box or the X box (CboxM and XboxM). To compare their
effects on GATA-1 binding, Xenopus adult red blood cell
extract was used in addition to af®nity-puri®ed oocyte fac-
tor (Figs. 1B and 1A). For both the erythrocyte GATA-1 and
oocyte GATA-2, competition was ef®cient when the X site
was mutated (XboxM), with binding of the labeled probe
completely abolished with a 25-fold excess of this oligonu-
cleotide (Fig. 1A, lanes 9±12; Fig. 1B, lanes 7±10). However,
with CboxM as competitor, a reproducible difference be-
tween the two extracts was evident: binding to the probe
remained unaffected with erythrocyte GATA-1 (Fig. 1B,
lanes 11±14), whereas oocyte protein binding was eventu-
ally abolished by this competitor, albeit only with a 50-foldFIG. 9. (A) Analysis by 5* end S1 mapping of the transcripts of
excess (Fig. 1A, lanes 13±16). Nevertheless, the failure tothe bH-gene constructs pbH-98Eco and pbH-98CEco injected into
oocytes incubated with and without 30 mM butyrate after injec- compete for binding at lower concentrations demonstrates
tion. 7.5 ng of each construct was injected per oocyte. Lanes 1 that the Cbox is the main contributor to binding by the
and 3 show injection of constructs into oocytes incubated without XboxM oligonucleotide, thus showing that site C is the
butyrate. Lanes 2 and 4, oocytes incubated with 30 mM butyrate main region for oocyte GATA-2 binding to the oligonucleo-
after injection. Lanes 1 and 2, injection of pbH-98CEco. Lanes 3 tide. In conclusion, these results are in accord with the
and 4, injection of pbH-98Eco. Lane 5, 2.4 mg of total 14-day chick transcription data, both GATA binding sites play a role in
embryo red blood cell RNA. Lane M, fX174/HaeIII marker. On the
the transcription of the bH gene in oocytes, but the strongerleft of the ®gure is denoted from top to bottom: M, probe/transcript
GATA binding site C plays the major role.mismatch bands; T, TATA box site; Cap, authentic cap site tran-
scripts. (B) A comparison of the transcripts synthesized in oocytes
injected with bH-gene constructs pbH-98Eco, pbH-98XEco, and
pbH-98CEco. 10 ng of each bH-gene construct was injected per DISCUSSION
oocyte. Lane 1, pbH-98Eco. Lane 2, pbH-98XEco. Lane 3, pbH-
98CEco. Lane M, fX174/HaeIII marker. On the left of the ®gure In this paper we show that Xenopus oocytes and embyros,
is denoted from top to bottom: M, probe/transcript mismatch both prior to and post-MBT, contain GATA-2 protein which
bands; T, TATA box site; C, authentic cap-site transcripts. All other is nuclear-located and complexed, but not chromatin
details are as for Fig. 8. bound. Furthermore, at least some of the oocyte GATA-
2 is available to function transcriptionally. EMSA results
demonstrated that the oocyte GATA binding activity has a
different sequence speci®city to that of GATA-1. The majortwo promoter mutant clones were produced, with each one
having one functional and one mutant GATA binding site difference is a much greater af®nity for the motif with a
core GATC sequence, and this difference is predominantly(Fig. 7, see Materials and Methods). A comparison (Fig. 9)
of the transcription of these clones in injected oocytes dem- manifest when the maternal GATA-2 is in a complexed
form. It was con®rmed that the GATA binding activity de-onstrated that mutation of site C virtually abolished tran-
scription from the cap site (Fig. 9A, lane 1 versus lane 3; tected by EMSA is GATA-2 by demonstrating that GATA-
2 monoclonal antibodies prevent binding of this factor toFig. 9B, lane 1 versus lane 3), both in the presence and
absence of butyrate (Fig. 9A, compare lanes 1 and 2 with 3 the GATC olignucleotide. Further con®rmation that the
oocyte factor is GATA-2 was obtained by using Westernand 4). Even the weaker GATA binding site X mutation
reduced cap site transcription to some extent (Fig. 9B, com- blotting with an af®nity-puri®ed polyclonal antibody raised
against a Xenopus GATA-2-speci®c peptide. It has beenpare lanes 1 and 2). The decrease in cap site transcription
was accompanied by an increase in initiations in the TATA shown previously that selecting random oligonucleotides
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for those recognized by GATA-1 yielded almost exclusively vation of the Xenopus GATA-2 gene, is located in the cyto-
plasm until the beginning of gastrulation at which timesequences containing the core motif GATA, whereas in the
same analysis both GATA-2 and GATA-3 recognized addi- migration to the nucleus occurs to activate the zygotic gene
(Brewer et al., 1995). Another example is Xnf7 which istional sequences particularly those with the core motif
GATC (Ko and Engel, 1993). That GATC is a bona ®de in located in the GV of early-stage oocytes, but migrates to
the cytoplasm of stage VI oocytes, where it is located untilvivo GATA-2 binding site has been demonstrated recently
when it was shown that either or both GATA-2 and GATA- the midblastula stage (Miller et al., 1991). It is then dephos-
phorylated and reenters the nucleus. The authors suggest3 are required to obtain activity of the trophoblast-speci®c
gene, placental lactogen 1. The GATA factor binding sites that phosphorylation may be a general mechanism by which
transfer of proteins from cytoplasm to nucleus is regulatedwithin this promoter were mapped by in vitro footprinting,
revealing two closely adjacent binding sites, a strong bind- in the developing embyro. Maternal transcription factors
located in the oocyte GV include OZ-1 which appears toing site GATCTT and a weaker site GATTT (Ng et al.,
1994). have a function in activating a wide variety of genes during
early development (Ovsenek et al., 1992; Zapp et al., 1993).While the nature of the GATA-2 complex in oocytes and
embyros is unknown, some recent ®ndings may be relevant. It has been reported that the transcriptional quiescence of
polymerase II genes prior to MBT in Xenopus results in partGATA factors have been shown to be complexed in discrete
nuclear bodies or foci within the nuclei of erythroleukemia from a de®ciency in transcriptional activators, suggesting a
functional constraint on their transcriptional competencecells and murine hematopoietic cells (Elefanty et al., 1996).
Moreover, these foci do not appear to be sites of active (Almouzni and Wolffe, 1995). This would be so if the factors
were sequestered either in the cytoplasm or the nucleus.transcription nor is there evidence of association with other
transcription factors. The function of these foci is unknown. To determine whether the oocyte GATA-2 is functional
as a transcription factor, a comparison was made of theIn addition, an in vivo association of GATA factors with
other transcription factors has also been reported by Osada transcriptional activity in injected oocytes of a wild-type
chicken bH-globin gene promoter with deletion constructset al. (1995) who demonstrated that there is a direct interac-
tion in vivo between the LIM protein RBTN2, the basic and it was shown that a -98 bH clone contained all the factor
binding sites necessary for correct cap site transcription inhelix±loop±helix protein TAL1/SCL and either GATA-1
or -2. These authors furthermore suggested that this associa- oocytes. Mutation of either of the GATA binding sites
within this region reduced cap site transcription, but thistion of the three factors could alter the binding speci®city
of GATA and TAL1/SCL. effect was more pronouced when the stronger of the two
sites was mutated, demonstrating that GATA-2 binding atIt is possible that complexing of the maternal Xenopus
GATA-2 plays a role in development by restricting the range these sites is required to get full transcriptional ef®ciency
from the cap site in oocytes and that at least some of theof GATA sequences to which it can bind and hence limit
the potential genes to be activated to those with very high maternal GATA-2 is available for transcriptional activation.
When butyrate-treated oocytes were injected with bH-glo-af®nity sites. The restricted availability of the maternal
GATA-2 may be necessary to allow development to proceed bin gene constructs cap site transcription was stimulated
up to 17-fold, in an analogous manner to that observed pre-during embyrogenesis as ectopic overexpression of GATA-
2 has been shown to prevent differentiation (Briegel et al., viously for the human g-globin gene (Partington et al.,
1984). The effect of sodium butyrate on chromatin structure1993).
A potential gene candidate for regulation by GATA-2 in is well-documented. The level of nucleosome core histone
acetylation is enhanced (Riggs et al., 1977; Vidali et al.,oocytes is the sperm receptor gene; the oocyte-speci®c ex-
pression of this gene has been reported to be dependent on 1978) as a consequence of histone deacetylase inhibition
(Candido et al., 1978). However, recently the intriguing ob-an unidenti®ed mouse maternal GATA-like factor
(Schickler et al., 1992). A GATA factor has also been re- servation was reported that butyrate treatment during Xen-
opus embyrogenesis does not promote hyperacetylation ofported in the oocytes of a number of reptilian species (Singh
et al., 1994). Thus the presence of maternal GATA factors histones prior to gastrulation (Dimitrov et al., 1993). These
results suggest that butyrate stimulation of bH gene tran-appears to be conserved among vertebrates.
The roles of maternal transcription factors in subsequent scription in oocytes does not result from chromatin modi-
®cation but from modi®cation of some component(s) of theembryonic development in Drosophila are relatively well
understood (for a review see St. Johnston and Nusslein-Vol- transcription machinery. It is clear that all factor binding
sites necessary for both basal and butyrate-stimulated tran-hand, 1992). In contrast, although maternal factors clearly
play a role in Xenopus development, most studies have ad- scription of the bH-globin gene in oocytes are downstream
of the 5*-¯anking PstI restriction site. A comparison bydressed the function only of those inherited as maternal
mRNA (for a review see Klymkowsky and Klymkowsky, EMSA of extracts prepared from control or butyrate-treated
oocytes revealed no difference in the level of GATA binding1994). Where studied, the proteins have been found to be
stored in the cytoplasm and released to migrate to the nu- activity (data not shown). Furthermore, Western analysis
of total oocyte GATA-2 protein showed no change to thecleus later in development. Recently we reported that a
maternal CCAAT factor, necessary for transcriptional acti- amount of GATA-2 present in butyrate-treated compared
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with a novel class of nuclear bodies in erythroblasts and mega-to control oocytes (data not shown). These results suggest
karyocytes. EMBO J. 15, 319±333.that the butyrate stimulation of transcription cannot be at-
Evans, T., Reitan, M., and Felsenfeld, G. (1988). An erythroid-spe-tributed to an enhancement of GATA-2 activity unless this
ci®c DNA-binding factor recognizes a regulatory sequence com-acts via a change in the GATA-2 interaction with other
mon to all chicken globin genes Proc. Natl. Acad. Sci. USA 85,factors. In this system butyrate may function to alter the
5976±5980.
signal transduction pathways by the modulation of serine/ Jiang, Y., and Evans, T. (1996). The Xenopus GATA-4/5/6 genes
threonine kinases, in a similar way to that reported to occur are associated with cardiac speci®cation and can regulate cardiac-
in ovarian carcinoma cells (Krupitza et al., 1995). speci®c transcription during embryogenesis. Dev. Biol. 174, 258±
Future work will address the role of the maternal GATA- 270.
2 protein in early development and the nature of the cofac- Kelley, C., Yee, K., Harland, R., and Zon, L. I. (1994). Ventral Ex-
pression of GATA-1 and GATA-2 in the Xenopus embryo de®nestors that modulate binding site speci®ty, and hence the se-
induction of hematopoietic mesoderm. Dev. Biol. 165, 193±205.lectivity of gene activation.
Klymkowsky, M. W., and Klymkowsky, A. (1994). Morphogenesis
and the cytoskeleton: Studies of the Xenopus embyro. Dev. Biol.
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